LAVAL, Quebec, July 10, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it plans to release second quarter 2017 financial results on Tuesday, Aug. 8, 2017. The Company will host a conference call and live webcast at 8:00 a.m. EDT to discuss the results and provide a business update. All materials will be made available on the investor relations portion of the corporate website before the start of the conference call.
Conference Call Details
Date |
Tuesday, Aug. 8, 2017 |
Time | 8:00 a.m. EDT |
Webcast | |
Participant Event Dial-in | (877) 876-8393 (North America) |
(443) 961-0178 (International) | |
Participant Passcode | 35736021 |
Replay Dial-in | (855) 859-2056 (North America) |
(404) 537-3406 (International) | |
Replay Passcode | 31833 (replay available until Oct. 8, 2017) |
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Investor Contacts: | ||
Arthur Shannon | Elif McDonald | |
514-856-3855 | 514-856-3855 | |
877-281-6642 (toll free) | 877-281-6642 (toll free) |
Media Contact: | |
Lainie Keller | |
908-927-0617 |
View original content with multimedia:http://www.prnewswire.com/news-releases/valeant-announces-q2-2017-financial-results-date-and-conference-call-details-300485451.html
SOURCE Valeant Pharmaceuticals International, Inc.
